Halozyme Therapeutics Inc (HALO) — Free Cash Flow Generation Index
Halozyme Therapeutics Inc (HALO) has a Free Cash Flow Generation Index of 0.98x as of September 2025. Free cash flow of $175.57 Million represents 1% of operating cash flow ($178.60 Million). Read Halozyme Therapeutics Inc debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Halozyme Therapeutics Inc Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Halozyme Therapeutics Inc across 7 annual periods. Explore HALO capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Halozyme Therapeutics Inc (2006–2024)
Year-by-year Free Cash Flow Generation Index for Halozyme Therapeutics Inc. For the full company profile including market capitalisation, see HALO company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.98x | $468.37 Million | $479.06 Million | $10.70 Million | ▲ +1.8% |
| 2023 | 0.96x | $373.28 Million | $388.57 Million | $15.29 Million | ▼ -2.0% |
| 2022 | 0.98x | $235.30 Million | $240.11 Million | $4.81 Million | ▼ -1.5% |
| 2021 | 1.00x | $297.98 Million | $299.44 Million | $1.46 Million | ▲ +4.2% |
| 2020 | 0.95x | $52.95 Million | $55.45 Million | $2.50 Million | ▼ -3.5% |
| 2017 | 0.99x | $132.70 Million | $134.05 Million | $1.35 Million | ▲ +4.4% |
| 2006 | 0.95x | $6.71 Million | $7.08 Million | $364.80K | — |